Samenvatting
Volledige samenvatting - paard & rund - virale ziekten, prionziekten, zoönosen
2 keer bekeken
0 keer verkocht
Dit is een uitgebreide samenvatting van de virale ziekten, prionziekten en zoönosen van paard en rund. Gemaakt in het academie jaar 2024 en gegeven door prof Jolien Van Cleemput. Belangrijke zaken staan in het vet en zijn onderlijnd, dit maakt het studeren ook overzichtelijker. Alles wat de prof...
[Meer zien]
Voorbeeld 4 van de 126 pagina's
Geupload op
25 december 2024
Aantal pagina's
126
Geschreven in
2024/2025
Type
Samenvatting
€11,99
100% tevredenheidsgarantie
Direct beschikbaar na betaling
Zowel online als in PDF
Je zit nergens aan vast
VIRALE ZIEKTEN, PRIONZIEKTEN EN
ZOÖNOSEN
INHOUDSOPGAVE
INLEIDING .................................................................................................................................... 5
HERHALING ALGEMENE VIROLOGIE – BASISPRINCIPES ....................................................................................5
EQUINE INFLUENZA VIRUS / EIV ...................................................................................................17
STRUCTUUR: INFLUENZAVIRUS ............................................................................................................... 17
PATHOGENESE .................................................................................................................................. 18
SYMPTOMEN ..................................................................................................................................... 20
DIAGNOSE........................................................................................................................................ 22
BEHANDELING ................................................................................................................................... 22
PREVENTIE........................................................................................................................................ 23
EQUINE HERPESVIRUS TYPE 1 EN 4 / EHV-1, EHV-4 .......................................................................24
PATHOGENESE .................................................................................................................................. 25
SYMPTOMEN ..................................................................................................................................... 25
HERPESVIRUS REPLICATIE: LYTISCHE REPLICATIE ........................................................................................ 29
OVERZICHT PATHOGENESE ................................................................................................................... 30
CNS = EQUINE HERPES MYLOENCEPHALOPATIE (EHM) ................................................................................. 31
DIAGNOSE........................................................................................................................................ 32
BEHANDELING EN BESTRIJDING .............................................................................................................. 32
PREVENTIE........................................................................................................................................ 33
EQUINE HERPESVIRUS TYPE 2 EN 5 / EHV-2, EHV-5 .......................................................................37
SYMPTOMEN ..................................................................................................................................... 37
PATHOGENESE EHV-5 ........................................................................................................................ 37
DIAGNOSE........................................................................................................................................ 38
BEHANDELING ................................................................................................................................... 39
EQUINE HERPESVIRUS TYPE 3 / EHV-3 ..........................................................................................40
PATHOGENESE: PRIMAIRE REPLICATIE - LATENTIE – REACTIVATIE ...................................................................... 40
SYMPTOMEN ..................................................................................................................................... 40
DIAGNOSE ........................................................................................................................................ 41
BEHANDELING ................................................................................................................................... 41
PAPILLOMAVIRUS EN SARCOÏD ....................................................................................................42
SYMPTOMEN ..................................................................................................................................... 42
DIAGNOSE........................................................................................................................................ 42
BEHANDELING ................................................................................................................................... 42
BOVINE PAPILLOMAVIRUS TYPE 1 EN TYPE 2 ............................................................................................... 42
PATHOGENESE .................................................................................................................................. 43
1
, KLINISCHE TYPEN SARCOÏDEN................................................................................................................ 44
DIFFERENTIAAL DIAGNOSE .................................................................................................................... 45
DIAGNOSE........................................................................................................................................ 45
BEHANDELING ................................................................................................................................... 45
EQUINE ROTA EN CORONAVIRUSSEN ...........................................................................................48
PATHOGENESE .................................................................................................................................. 48
SYMPTOMEN ..................................................................................................................................... 49
DIAGNOSE........................................................................................................................................ 49
IMMUNITEIT ....................................................................................................................................... 50
BEHANDELING ................................................................................................................................... 51
PREVENTIE........................................................................................................................................ 51
EQUINE ARTERITIS VIRUS / EAV ....................................................................................................52
PATHOGENESE .................................................................................................................................. 52
PATHOGENESE EN SYMPTOMEN .............................................................................................................. 54
SYMPTOMEN ..................................................................................................................................... 55
IMMUNITEIT ....................................................................................................................................... 56
DIAGNOSE........................................................................................................................................ 56
CONTROLE EN PREVENTIE ..................................................................................................................... 57
EQUINE INFECTIEUZE ANEMIE VIRUS / EIAV ..................................................................................58
TRANSMISSIE..................................................................................................................................... 58
PATHOGENESE .................................................................................................................................. 59
SYMPTOMEN ..................................................................................................................................... 60
DIAGNOSE........................................................................................................................................ 60
CONTROLE EN PREVENTIE ..................................................................................................................... 61
WESTNIJLVIRUS ..........................................................................................................................62
TRANSMISSIE..................................................................................................................................... 62
SYMPTOMEN ..................................................................................................................................... 63
DIAGNOSE........................................................................................................................................ 64
BEHANDELING ................................................................................................................................... 64
CONTROLE ....................................................................................................................................... 64
BOVINE RESPIRATORY DISEASE / BRD / BOVIENE RESPIRATOIRE ZIEKTE .......................................65
ETIOLOGIE ........................................................................................................................................ 67
VIRUSSEN MET ENKEL TROPISME AHS ...................................................................................................... 67
VIRUSSEN MET O.A. TROPISME AHS ....................................................................................................... 68
TRANSMISSIE..................................................................................................................................... 69
PATHOGENESE - NAÏEF DIER .................................................................................................................. 70
PATHOGENESE – IMMUUN DIER .............................................................................................................. 71
PATHOGENESE – SECUNDAIRE BACTERIËLE INFECTIE .................................................................................... 72
PATHOGENESE – HYPERACUUT VERLOOP .................................................................................................. 72
SYMPTOMEN ..................................................................................................................................... 72
DIAGNOSE........................................................................................................................................ 73
BEHANDELING ................................................................................................................................... 74
PREVENTIE........................................................................................................................................ 74
VIRALE SVS: BOVIENE ROTAVIRUS EN BOVIENE CORONAVIRUS ....................................................78
2
, VIRALE SPIJSVERTERINGSSTOORNISSEN .................................................................................................... 78
PATHOGENESE .................................................................................................................................. 78
SYMPTOMEN ..................................................................................................................................... 79
DIAGNOSE........................................................................................................................................ 79
IMMUNITEIT ....................................................................................................................................... 79
BEHANDELING ................................................................................................................................... 81
PREVENTIE........................................................................................................................................ 81
MOND EN KLAUWZEERVIRUS .......................................................................................................83
TRANSMISSIE..................................................................................................................................... 84
PATHOGENESE: PRIMAIRE REPLICATIE – VIREMIE – SECUNDAIRE REPLICATIE ........................................................ 84
SYMPTOMEN ..................................................................................................................................... 85
DIFFERENTIAAL DIAGNOSE .................................................................................................................... 86
DIAGNOSE........................................................................................................................................ 88
BESTRIJDING ..................................................................................................................................... 90
BLAUWTONGVIRUS .....................................................................................................................92
TRANSMISSIE..................................................................................................................................... 92
PATHOGENESE .................................................................................................................................. 92
SYMPTOMEN ..................................................................................................................................... 93
DIAGNOSE, BEHANDELING EN PREVENTIE .................................................................................................. 94
UITBRAKEN ....................................................................................................................................... 95
BOVIENE PAPILLOMAVIRUSES .....................................................................................................96
TRANSMISSIE..................................................................................................................................... 96
PATHOGENESE BPV1-2 (EN 3 IN AUSTRALIË) ............................................................................................ 96
SYMPTOMEN ..................................................................................................................................... 97
PATHOGENESE BPV4 (SCHOTLAND) ....................................................................................................... 97
SYMPTOMEN ..................................................................................................................................... 97
PATHOGENESE BPV5-6....................................................................................................................... 97
SYMPTOMEN ..................................................................................................................................... 98
PATHOGENESE BPVS .......................................................................................................................... 98
PATHOGENESE BPV3,4 EN 6 ................................................................................................................ 98
PATHOGENESE BPV1,2 EN 5 ................................................................................................................ 98
IMMUNITEIT ....................................................................................................................................... 98
BEHANDELING EN PREVENTIE................................................................................................................. 99
AUJESZKY VIRUS ....................................................................................................................... 100
TRANSMISSIE TUSSEN VARKENS ............................................................................................................ 100
TRANSMISSIE VARKENS – ANDERE ZOOGDIEREN ........................................................................................ 100
PATHOGENESE RUND ........................................................................................................................ 101
SYMPTOMEN RUND ........................................................................................................................... 101
DIAGNOSE...................................................................................................................................... 102
BESTRIJDING ................................................................................................................................... 102
BOVIENE SPONGIFORME ENCEPHALOPATHIE (BSE) .................................................................... 103
PATHOGENESE ................................................................................................................................ 105
PATHOGENESE – NORMALE NEURONALE CEL............................................................................................ 105
PATHOGENESE ................................................................................................................................ 106
SYMPTOMEN ................................................................................................................................... 106
3
, DIAGNOSE...................................................................................................................................... 107
BESTRIJDING ................................................................................................................................... 107
SPECIFIEK RISICOMATERIAAL ............................................................................................................... 108
BESTRIJDING ................................................................................................................................... 108
BSE GEVAAR VOOR DE MENS? ............................................................................................................. 108
VCJD ............................................................................................................................................ 109
BOVINE VIRALE DIARREE VIRUS (BVDV) ...................................................................................... 110
CP EN NCP BIOTYPE......................................................................................................................... 110
PATHOGENESE – NCP EN CP NAÏEF DIER ............................................................................................... 111
PATHOGENESE NAÏEF DRACHTIG RUND – NCP ......................................................................................... 112
SYMPTOMEN ................................................................................................................................... 113
PATHOGENESE NAÏEF DRACHTIG RUND - CP ............................................................................................ 113
PATHOGENESE PERSISTENT VIREMISCH IMMUNOTOLERANT RUND – NCP ........................................................ 113
PATHOGENESE PERSISTENT VIREMISCH IMMUNOTOLERANT RUND – CP & NCP ................................................ 113
DIAGNOSE...................................................................................................................................... 115
BESTRIJDING VOOR 2015: SANERING VAN EEN BVD-POSITIEF BEDRIJF ........................................................... 116
BESTRIJDING NA 2015 ....................................................................................................................... 117
BOVIENE HERPESVIRUS TYPE 1 (BHV-1) ...................................................................................... 118
PATHOGENESE PRIMAIRE INFECTIE ........................................................................................................ 118
PATHOGENESE REACTIVATIE ................................................................................................................ 119
SYMPTOMEN ................................................................................................................................... 120
SYMPTOMEN MENINGO-ENCEPHALITIS (BHV-5) ...................................................................................... 121
SYMPTOMEN IPV (BHV1.2) ............................................................................................................... 121
SYMPTOMEN IPB (BHV1.2) ............................................................................................................... 121
DIAGNOSE...................................................................................................................................... 122
BEHANDELING ................................................................................................................................. 122
PREVENTIE EN ERADICATIE .................................................................................................................. 122
PREVENTIE EN ERADICATIE IN BELGIË ..................................................................................................... 124
BOOSAARDIGE CATARRAALKOORTS (BKK).................................................................................. 125
PATHOGENESE ................................................................................................................................ 125
SYMPTOMEN ................................................................................................................................... 125
DIAGNOSE – BEHANDELING - PREVENTIE ................................................................................................. 126
4